Buy Cyclopam

Cyclopam

What is Cyclopam?

Cyclopam is a branded medication that combines dicyclomine (20 mg) and paracetamol (500 mg) in a single oral pill. The product belongs to the digestive health therapeutic class and is marketed in the United Kingdom under the supervision of the Medicines and Healthcare products Regulatory Agency (MHRA). It is available only by prescription (Rx) and is intended for the temporary relief of abdominal cramps and associated pain.

How Cyclopam Works in the Body

• Dicyclomine is an antispasmodic that blocks muscarinic acetylcholine receptors in the smooth muscle of the gastrointestinal (GI) tract. By reducing the activity of these receptors, the drug relaxes the intestinal wall, lessening spasms that cause cramping.
• Paracetamol (acetaminophen) acts centrally to inhibit the synthesis of prostaglandins, which are chemicals that amplify pain signals and raise body temperature. This provides analgesic (pain-relieving) and antipyretic (fever-reducing) effects.
• The combination allows rapid relief of painful abdominal spasms while simultaneously lowering any associated fever or mild pain that may accompany digestive disorders.
• Onset of action for dicyclomine is usually within 30 minutes, with peak effects around 1-2 hours; paracetamol reaches peak plasma concentrations in about 30-60 minutes. Both agents have a duration of action of 4-6 hours, making the single tablet suitable for short-term symptom control.

Conditions Treated by Cyclopam

Cyclopam is licensed in the UK for the symptomatic treatment of:

• Irritable bowel syndrome (IBS)-related abdominal cramps when other lifestyle measures are insufficient.
• Acute functional gastrointestinal spasm associated with dyspepsia, gastroenteritis, or medication-induced cramping.
• Mild to moderate abdominal pain where a combination of antispasmodic and analgesic action is clinically appropriate.

The medication is not indicated for chronic inflammatory bowel disease, obstructive GI disorders, or for the treatment of fever without an accompanying GI complaint.

Patient Suitability and Contraindications

Who Should Use Cyclopam?

• Adults (≥ 18 years) experiencing intermittent abdominal cramping with mild to moderate pain.
• Individuals without a history of severe liver disease, glaucoma, urinary retention, or known hypersensitivity to either ingredient.

Absolute Contraindications

• Known hypersensitivity to dicyclomine, paracetamol, or any excipients in the pill.
• Severe hepatic impairment (e.g., Child-Pugh class C) because paracetamol metabolism relies on liver function.
• Narrow-angle glaucoma, significant urinary retention, or gastrointestinal obstruction.
• Pregnancy in the first trimester (dicyclomine is category C) without a clear risk-benefit assessment.

Relative Contraindications

• Mild to moderate hepatic disease - dose may need adjustment, and total daily paracetamol should not exceed 2 g.
• Elderly patients - increased sensitivity to anticholinergic effects (dry mouth, dizziness).
• Concurrent use of other anticholinergic drugs (e.g., antihistamines, tricyclic antidepressants) - may heighten dry-mouth or constipation risk.
• Warfarin therapy - paracetamol can potentiate anticoagulation; monitoring of INR is advised.

Special Populations

• Pregnancy: Use only if the expected benefit outweighs potential risk; avoid in the first trimester unless essential.
• Lactation: Small amounts of both agents enter breast milk; generally considered compatible, but caution is advised for infants with hepatic vulnerability.
• Pediatrics: Cyclopam is not approved for patients under 18 years of age.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Dry mouth
• Blurred vision
• Constipation or reduced bowel motility
• Dizziness or light-headedness
• Nausea (usually mild)

These symptoms are often transient and may diminish with continued use or dose reduction.

Serious Adverse Events

• Severe allergic reactions (rash, swelling, anaphylaxis) - seek emergency care.
• Acute hepatic injury from paracetamol overdose - symptoms include right-upper-quadrant pain, jaundice, or elevated liver enzymes.
• Urinary retention or worsening of glaucoma caused by anticholinergic activity.

If any of these occur, discontinue Cyclopam and consult a healthcare professional immediately.

Drug Interactions

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin) can increase dicyclomine plasma levels, heightening anticholinergic side effects.
• Warfarin - concurrent paracetamol may raise INR; periodic monitoring is recommended.
• Other anticholinergic agents (e.g., diphenhydramine, oxybutynin) - additive dry-mouth, constipation, and blurred-vision risk.
• Alcohol - potentiates paracetamol-related liver toxicity; limit intake while using Cyclopam.

Food and Lifestyle Interactions

• Take the tablet with a full glass of water; it may be taken with or without food.
• Avoid excessive alcohol consumption.
• Caution when operating machinery or driving if you experience dizziness or blurred vision.

How to Take Cyclopam

• Standard dosing: One tablet (20 mg dicyclomine / 500 mg paracetamol) up to four times daily as needed for abdominal cramps. The total daily paracetamol dose must not exceed 4 g (i.e., eight tablets).
• Maximum duration: Do not use continuously for more than 7 days without medical review.
• Renal or hepatic adjustment: In moderate liver disease, limit use to two tablets per day and keep total paracetamol intake ≤ 2 g. No dose adjustment is required for normal renal function.
• Administration tips: Swallow the pill whole; do not crush or chew. Store at room temperature (15-30 °C), away from moisture and direct sunlight.
• Missed dose: If you miss a dose and it is within a reasonable time, take it; otherwise, skip and resume the regular schedule. Do not double-dose to make up for a missed tablet.
• Overdose guidance: Symptoms may include nausea, vomiting, right-upper-quadrant pain, or severe drowsiness. Seek emergency medical care; activated charcoal may be considered if presentation is early. N-acetylcysteine is the antidote for paracetamol toxicity.

Monitoring and Follow-Up

• Liver function tests (ALT, AST, bilirubin) should be performed if Cyclopam is used for more than a week or if the patient has pre-existing liver disease.
• Clinical assessment of symptom relief and side-effect profile at each follow-up visit (typically within 1-2 weeks of initiation).
• Blood pressure and heart rate may be monitored in patients with known cardiac disease because anticholinergic agents can cause tachycardia.

If any new or worsening symptoms arise, contact your prescriber promptly.

Storage and Handling

• Keep the bottle tightly closed and store at room temperature, protected from light and moisture.
• Do not use tablets after the expiry date printed on the packaging.
• Child safety: Store out of reach of children; the bottle has a child-resistant cap.
• Dispose of unused tablets according to local pharmacy take-back schemes or follow MHRA guidance for safe disposal.

Medication-Specific Glossary

Anticholinergic

A substance that blocks the action of the neurotransmitter acetylcholine at muscarinic receptors, leading to reduced smooth-muscle contraction and decreased secretions.

Hepatotoxicity

Chemical-induced liver damage; for paracetamol, toxicity occurs when metabolic pathways become saturated, leading to accumulation of a harmful metabolite.

First-Pass Metabolism

The rapid uptake and biotransformation of a drug by the liver after oral administration, which reduces the amount of active drug reaching systemic circulation.

Therapeutic Window

The dosage range in which a medication provides clinical benefit without unacceptable adverse effects.

Medical Disclaimer

This article provides educational information about Cyclopam and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.